Close Menu

NEW YORK – Germany's government-funded health insurance will start covering three additional breast cancer biomarker tests that can help doctors and patients decide whether adjuvant chemotherapy after surgery is indicated.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.